Click for best price
Antispasmodics Drugs Market Size, Share 2023
One type of antispasmodic is used for smooth muscle contraction, especially in the tubular organs of the gastrointestinal tract. The effect is to prevent cramps in the stomach, intestines or bladder.
This report aims to provide a comprehensive presentation of the global market for Antispasmodics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antispasmodics Drugs. This report contains market size and forecasts of Antispasmodics Drugs in global, including the following market information:
Global Antispasmodics Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Antispasmodics Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antispasmodics Drugs include Allergan, Hikma Pharmaceuticals, Lannett, Mylan, Nexus Pharmaceuticals, Akorn, Aurobindo Pharma, Daiichi Sankyo and Fresenius Kabi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antispasmodics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antispasmodics Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Antispasmodics Drugs Market Segment Percentages, by Type, 2022 (%)
Oral
Injectable
Others
Global Antispasmodics Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Antispasmodics Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Special Clinic
Home Care
Others
Global Antispasmodics Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Antispasmodics Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antispasmodics Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antispasmodics Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Hikma Pharmaceuticals
Lannett
Mylan
Nexus Pharmaceuticals
Akorn
Aurobindo Pharma
Daiichi Sankyo
Fresenius Kabi
Shanghai Fosun Pharmaceutical
SunGen Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antispasmodics Drugs, market overview.
Chapter 2: Global Antispasmodics Drugs market size in revenue.
Chapter 3: Detailed analysis of Antispasmodics Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antispasmodics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antispasmodics Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antispasmodics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antispasmodics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antispasmodics Drugs Overall Market Size
2.1 Global Antispasmodics Drugs Market Size: 2022 VS 2032
2.2 Global Antispasmodics Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antispasmodics Drugs Players in Global Market
3.2 Top Global Antispasmodics Drugs Companies Ranked by Revenue
3.3 Global Antispasmodics Drugs Revenue by Companies
3.4 Top 3 and Top 5 Antispasmodics Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antispasmodics Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antispasmodics Drugs Players in Global Market
3.6.1 List of Global Tier 1 Antispasmodics Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Antispasmodics Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antispasmodics Drugs Market Size Markets, 2022 & 2032
4.1.2 Oral
4.1.3 Injectable
4.1.4 Others
4.2 By Type - Global Antispasmodics Drugs Revenue & Forecasts
4.2.1 By Type - Global Antispasmodics Drugs Revenue, 2018-2023
4.2.2 By Type - Global Antispasmodics Drugs Revenue, 2024-2032
4.2.3 By Type - Global Antispasmodics Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antispasmodics Drugs Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Special Clinic
5.1.4 Home Care
5.1.5 Others
5.2 By Application - Global Antispasmodics Drugs Revenue & Forecasts
5.2.1 By Application - Global Antispasmodics Drugs Revenue, 2018-2023
5.2.2 By Application - Global Antispasmodics Drugs Revenue, 2024-2032
5.2.3 By Application - Global Antispasmodics Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Antispasmodics Drugs Market Size, 2022 & 2032
6.2 By Region - Global Antispasmodics Drugs Revenue & Forecasts
6.2.1 By Region - Global Antispasmodics Drugs Revenue, 2018-2023
6.2.2 By Region - Global Antispasmodics Drugs Revenue, 2024-2032
6.2.3 By Region - Global Antispasmodics Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Antispasmodics Drugs Revenue, 2018-2032
6.3.2 US Antispasmodics Drugs Market Size, 2018-2032
6.3.3 Canada Antispasmodics Drugs Market Size, 2018-2032
6.3.4 Mexico Antispasmodics Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Antispasmodics Drugs Revenue, 2018-2032
6.4.2 Germany Antispasmodics Drugs Market Size, 2018-2032
6.4.3 France Antispasmodics Drugs Market Size, 2018-2032
6.4.4 U.K. Antispasmodics Drugs Market Size, 2018-2032
6.4.5 Italy Antispasmodics Drugs Market Size, 2018-2032
6.4.6 Russia Antispasmodics Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Antispasmodics Drugs Market Size, 2018-2032
6.4.8 Benelux Antispasmodics Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Antispasmodics Drugs Revenue, 2018-2032
6.5.2 China Antispasmodics Drugs Market Size, 2018-2032
6.5.3 Japan Antispasmodics Drugs Market Size, 2018-2032
6.5.4 South Korea Antispasmodics Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Antispasmodics Drugs Market Size, 2018-2032
6.5.6 India Antispasmodics Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Antispasmodics Drugs Revenue, 2018-2032
6.6.2 Brazil Antispasmodics Drugs Market Size, 2018-2032
6.6.3 Argentina Antispasmodics Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antispasmodics Drugs Revenue, 2018-2032
6.7.2 Turkey Antispasmodics Drugs Market Size, 2018-2032
6.7.3 Israel Antispasmodics Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Antispasmodics Drugs Market Size, 2018-2032
6.7.5 UAE Antispasmodics Drugs Market Size, 2018-2032
7 Antispasmodics Drugs Companies Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Antispasmodics Drugs Major Product Offerings
7.1.4 Allergan Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Hikma Pharmaceuticals
7.2.1 Hikma Pharmaceuticals Company Summary
7.2.2 Hikma Pharmaceuticals Business Overview
7.2.3 Hikma Pharmaceuticals Antispasmodics Drugs Major Product Offerings
7.2.4 Hikma Pharmaceuticals Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.2.5 Hikma Pharmaceuticals Key News & Latest Developments
7.3 Lannett
7.3.1 Lannett Company Summary
7.3.2 Lannett Business Overview
7.3.3 Lannett Antispasmodics Drugs Major Product Offerings
7.3.4 Lannett Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.3.5 Lannett Key News & Latest Developments
7.4 Mylan
7.4.1 Mylan Company Summary
7.4.2 Mylan Business Overview
7.4.3 Mylan Antispasmodics Drugs Major Product Offerings
7.4.4 Mylan Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.4.5 Mylan Key News & Latest Developments
7.5 Nexus Pharmaceuticals
7.5.1 Nexus Pharmaceuticals Company Summary
7.5.2 Nexus Pharmaceuticals Business Overview
7.5.3 Nexus Pharmaceuticals Antispasmodics Drugs Major Product Offerings
7.5.4 Nexus Pharmaceuticals Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.5.5 Nexus Pharmaceuticals Key News & Latest Developments
7.6 Akorn
7.6.1 Akorn Company Summary
7.6.2 Akorn Business Overview
7.6.3 Akorn Antispasmodics Drugs Major Product Offerings
7.6.4 Akorn Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.6.5 Akorn Key News & Latest Developments
7.7 Aurobindo Pharma
7.7.1 Aurobindo Pharma Company Summary
7.7.2 Aurobindo Pharma Business Overview
7.7.3 Aurobindo Pharma Antispasmodics Drugs Major Product Offerings
7.7.4 Aurobindo Pharma Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.7.5 Aurobindo Pharma Key News & Latest Developments
7.8 Daiichi Sankyo
7.8.1 Daiichi Sankyo Company Summary
7.8.2 Daiichi Sankyo Business Overview
7.8.3 Daiichi Sankyo Antispasmodics Drugs Major Product Offerings
7.8.4 Daiichi Sankyo Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.8.5 Daiichi Sankyo Key News & Latest Developments
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Company Summary
7.9.2 Fresenius Kabi Business Overview
7.9.3 Fresenius Kabi Antispasmodics Drugs Major Product Offerings
7.9.4 Fresenius Kabi Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.9.5 Fresenius Kabi Key News & Latest Developments
7.10 Shanghai Fosun Pharmaceutical
7.10.1 Shanghai Fosun Pharmaceutical Company Summary
7.10.2 Shanghai Fosun Pharmaceutical Business Overview
7.10.3 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Major Product Offerings
7.10.4 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.10.5 Shanghai Fosun Pharmaceutical Key News & Latest Developments
7.11 SunGen Pharma
7.11.1 SunGen Pharma Company Summary
7.11.2 SunGen Pharma Business Overview
7.11.3 SunGen Pharma Antispasmodics Drugs Major Product Offerings
7.11.4 SunGen Pharma Antispasmodics Drugs Revenue in Global Market (2018-2023)
7.11.5 SunGen Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antispasmodics Drugs Market Opportunities & Trends in Global Market
Table 2. Antispasmodics Drugs Market Drivers in Global Market
Table 3. Antispasmodics Drugs Market Restraints in Global Market
Table 4. Key Players of Antispasmodics Drugs in Global Market
Table 5. Top Antispasmodics Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antispasmodics Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antispasmodics Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antispasmodics Drugs Product Type
Table 9. List of Global Tier 1 Antispasmodics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antispasmodics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Antispasmodics Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Antispasmodics Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antispasmodics Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Antispasmodics Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Antispasmodics Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antispasmodics Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Antispasmodics Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Antispasmodics Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antispasmodics Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Antispasmodics Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antispasmodics Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Antispasmodics Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antispasmodics Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Antispasmodics Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antispasmodics Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Antispasmodics Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antispasmodics Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Antispasmodics Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antispasmodics Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Allergan Company Summary
Table 31. Allergan Antispasmodics Drugs Product Offerings
Table 32. Allergan Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Allergan Key News & Latest Developments
Table 34. Hikma Pharmaceuticals Company Summary
Table 35. Hikma Pharmaceuticals Antispasmodics Drugs Product Offerings
Table 36. Hikma Pharmaceuticals Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Hikma Pharmaceuticals Key News & Latest Developments
Table 38. Lannett Company Summary
Table 39. Lannett Antispasmodics Drugs Product Offerings
Table 40. Lannett Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Lannett Key News & Latest Developments
Table 42. Mylan Company Summary
Table 43. Mylan Antispasmodics Drugs Product Offerings
Table 44. Mylan Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Mylan Key News & Latest Developments
Table 46. Nexus Pharmaceuticals Company Summary
Table 47. Nexus Pharmaceuticals Antispasmodics Drugs Product Offerings
Table 48. Nexus Pharmaceuticals Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Nexus Pharmaceuticals Key News & Latest Developments
Table 50. Akorn Company Summary
Table 51. Akorn Antispasmodics Drugs Product Offerings
Table 52. Akorn Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Akorn Key News & Latest Developments
Table 54. Aurobindo Pharma Company Summary
Table 55. Aurobindo Pharma Antispasmodics Drugs Product Offerings
Table 56. Aurobindo Pharma Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Aurobindo Pharma Key News & Latest Developments
Table 58. Daiichi Sankyo Company Summary
Table 59. Daiichi Sankyo Antispasmodics Drugs Product Offerings
Table 60. Daiichi Sankyo Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Daiichi Sankyo Key News & Latest Developments
Table 62. Fresenius Kabi Company Summary
Table 63. Fresenius Kabi Antispasmodics Drugs Product Offerings
Table 64. Fresenius Kabi Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Fresenius Kabi Key News & Latest Developments
Table 66. Shanghai Fosun Pharmaceutical Company Summary
Table 67. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Product Offerings
Table 68. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Shanghai Fosun Pharmaceutical Key News & Latest Developments
Table 70. SunGen Pharma Company Summary
Table 71. SunGen Pharma Antispasmodics Drugs Product Offerings
Table 72. SunGen Pharma Antispasmodics Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. SunGen Pharma Key News & Latest Developments
List of Figures
Figure 1. Antispasmodics Drugs Segment by Type in 2022
Figure 2. Antispasmodics Drugs Segment by Application in 2022
Figure 3. Global Antispasmodics Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antispasmodics Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Antispasmodics Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antispasmodics Drugs Revenue in 2022
Figure 8. By Type - Global Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Antispasmodics Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Antispasmodics Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 16. US Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 28. China Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Antispasmodics Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Antispasmodics Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Allergan Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Hikma Pharmaceuticals Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Lannett Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Mylan Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Nexus Pharmaceuticals Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Akorn Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aurobindo Pharma Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Daiichi Sankyo Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Fresenius Kabi Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. SunGen Pharma Antispasmodics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
